Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide

3,4-dihydroxyphenylacetic acid has been researched along with n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardo, MT; Crooks, PA; Dwoskin, LP; Neugebauer, NM; Rahman, S; Zhang, Z1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide

ArticleYear
The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.
    European journal of pharmacology, 2008, Dec-28, Volume: 601, Issue:1-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Picolines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley

2008